Patent ID: 8840553

Claim:
A glucose monitoring device, comprising: a housing; a processor housed in said housing, wherein said processor processes one or more signals produced by a subcutaneously implanted glucose sensor, the one or more signals indicative of a glucose concentration in a subject, in order to: determine a dosage of medication based on the glucose concentration, determine a rate and/or acceleration in the increase or decrease in the glucose concentration in the subject, and adjust the determined dosage of medication based on the rate and/or acceleration in the increase or decrease in the glucose concentration to provide an adjusted dosage of medication; a display integrated with said housing and in communication with said processor, wherein said display is configured to display the adjusted dosage of medication and provide an indicator of the rate and/or acceleration in the increase or decrease in the glucose concentration in the subject; and a transmitter integrated with said housing and configured to communicate with the subcutaneously implanted glucose sensor.